PRODUCTS

  • > > Antiulcerants

    Okwe Delayed Release Microencapsulated Capsule

    English Name ：
    Okwe Delayed Release Microencapsulated Capsule
    R&D code ：
    DFA-351
    Product Licence  ：
    衛署藥製字第043842號
    NHI. NO. ：
    AC43842100
    Ingredients ：
    Omeprazole
    Dosage Form ：
    Delayed Release Microencapsulated Capsule
    Strength ：
    40 mg
    包裝規格 ：
    14's Bottle
    30's Bottle
    100's Bottle
    Marketing Status ：
    處方用藥
    Controlled Drugs ：
    NO
    Manufacturing Place ：
    Taiwan
    ATC Code ：
    A02BC01
    Indications  ：
    Duodenal ulcer, gastric ulcer, reflux esophagitis,Refractory duodenal ulcer ,Zollinger-Ellison syndrome,H. pylori eradication regimens in peptic ulcer disease.
    Dosage ：
    Duodenal ulcer, gastric ulcer, reflux esophagitis 20 mg once daily. Duration: 4 weeks in duodenal ulceration or 8 weeks in gastric ulcer & reflux esophagitis. Dose may be increased to 40 mg daily in severe cases. Refractory duodenal ulcer 40 mg once daily. Zollinger-Ellison syndrome Initially 60 mg daily. Maintenance: 20-120 mg daily. Dose > 80 mg should be given in 2 divided doses. H. pylori eradication regimens in peptic ulcer disease Omeprazole 40 mg with amoxicillin 2 g daily for 2 weeks.
    Package Insert ：
    V
    NHI. Price. ：
    8.4
    NHI. Effective Date ：
    106.09.01
    Licence Expire Day ：
    109/07/07
    Product Code ：
    4220014203504
    4220030213504
    4220100203504
產品資訊查詢:https://lmspiq.fda.gov.tw/web/DRPIQ/DRPIQ1000Result?licBaseId=ADB8F040-DF21-4228-B917-93AB08DB4F38
More
More Pro. Close Menu TOP